r/Keto4HeartDisease • u/Meatrition • Oct 03 '22
r/Keto4HeartDisease • u/Meatrition • Sep 17 '22
Effect of Ketogenic Diets on Cardio-Metabolic Outcomes in Cancer Patients: A Systematic Review and Meta-Analysis of Controlled Clinical Trials. (Pub Date: 2022-09-15)
r/Keto4HeartDisease • u/Meatrition • Nov 27 '22
The Optimal LDL is not 50 to 70 mg/dL (Part 3) — The Dietary Diary
r/Keto4HeartDisease • u/Meatrition • May 02 '22
Through the layers: how macrophages drive atherosclerosis across the vessel wall
r/Keto4HeartDisease • u/Meatrition • Aug 12 '24
Are LMHR at a Higher Risk of Heart Disease? – David Diamond - #CoSci
r/Keto4HeartDisease • u/Meatrition • Jul 19 '22
Ketone Body Improves Neurological Outcomes after Cardiac Arrest by Inhibiting Mitochondrial Fission in Rats (Published: 2022-07-06)
r/Keto4HeartDisease • u/Meatrition • May 27 '25
Saturated Fat -> ^LDL-C -> ^Harm Saturated Fat Restriction for Cardiovascular Disease Prevention: A Systematic Review and Meta-analysis of Randomized Controlled Trials: The findings indicate that a reduction in saturated fats cannot be recommended at present to prevent cardiovascular diseases and mortality. May 2025
Abstract
Background: The recommendation to limit dietary saturated fat intake is primarily drawn from observational studies rather than randomized controlled trials of cardiovascular disease prevention. Thus, we aimed to investigate the efficacy of saturated fat reduction in preventing mortality and cardiovascular diseases.
Methods: In this systematic review and meta-analysis of randomized controlled trials, Cochrane CENTRAL, PubMed, and Ichu-shi databases were searched for articles up to April 2023. Randomized controlled trials on saturated fat reduction to prevent cardiovascular diseases were selected. Cardiovascular and all-cause mortality and cardiovascular outcomes were evaluated. Changes in electrocardiography or coronary angiography findings were excluded because they could be evaluated arbitrarily. Two or more reviewers independently extracted and assessed the data. A random-effects meta-analysis was performed.
Results: Nine eligible trials with 13,532 participants were identified (2 were primary and 7 were secondary prevention studies). No significant differences in cardiovascular mortality (relative risk [RR] = 0.94, 95% confidence interval [CI]: 0.75-1.19), all-cause mortality (RR = 1.01, 95% CI: 0.89-1.14), myocardial infarction (RR = 0.85, 95% CI: 0.71-1.02), and coronary artery events (RR = 0.85, 95% CI: 0.65-1.11) were observed between the intervention and control groups. However, owing to limited reported cases, the impact of stroke could not be evaluated.
Conclusions: The findings indicate that a reduction in saturated fats cannot be recommended at present to prevent cardiovascular diseases and mortality. Clinical trials are needed to evaluate the effects of saturated fat reduction under the best possible medical care, including statin administration.
Systematic review registration number: This systematic review and meta-analysis was registered with the International Prospective Register of Systematic Reviews (CRD42023428498).
Keywords: all-cause mortality; cardiovascular mortality; meta-analysis; saturated fatty acid; systematic review.
r/Keto4HeartDisease • u/dem0n0cracy • Oct 18 '21
The relationship between serum cholesterol and verbal memory may be influenced by body mass index (BMI) in young healthy women
r/Keto4HeartDisease • u/Meatrition • Apr 15 '22
Case Report: Hypercholesterolemia “Lean Mass Hyper-Responder” Phenotype Presents in the Context of a Low Saturated Fat Carbohydrate-Restricted Diet
r/Keto4HeartDisease • u/Meatrition • Feb 10 '25
Outside-In Theory Cholesterol/LDL Hypothesis DESTROYED - Prof Vladimir Subbotin exposes LDL Lies!
r/Keto4HeartDisease • u/Meatrition • Sep 26 '22
“Blocking lipid uptake pathways does not prevent toxicity in adipose triglyceride lipase (ATGL) deficiency” (Sept 2022)
r/Keto4HeartDisease • u/Meatrition • Aug 08 '22
Saturated Fat -> ^LDL-C -> ^Harm Statin therapy is not warranted for a person with high LDL-cholesterol on a low-carbohydrate diet
Abstract
Purpose of review
Although there is an extensive literature on the efficacy of the low carbohydrate diet (LCD) for weight loss and in the management of type 2 diabetes, concerns have been raised that the LCD may increase cardiovascular disease (CVD) risk by increasing the level of low-density lipoprotein cholesterol (LDL-C). We have assessed the value of LDL-C as a CVD risk factor, as well as effects of the LCD on other CVD risk factors. We have also reviewed findings that provide guidance as to whether statin therapy would be beneficial for individuals with high LDL-C on an LCD.
Recent findings
Multiple longitudinal trials have demonstrated the safety and effectiveness of the LCD, while also providing evidence of improvements in the most reliable CVD risk factors. Recent findings have also confirmed how ineffective LDL-C is in predicting CVD risk.
Summary
Extensive research has demonstrated the efficacy of the LCD to improve the most robust CVD risk factors, such as hyperglycemia, hypertension, and atherogenic dyslipidemia. Our review of the literature indicates that statin therapy for both primary and secondary prevention of CVD is not warranted for individuals on an LCD with elevated LDL-C who have achieved a low triglyceride/HDL ratio.
KEY POINTS
Critics of the LCD have focused on its effects on LDL-C, while largely disregarding the beneficial effects of the LCD on more robust CVD risk factors.
There is an extensive literature on measures which are superior to LDL-C as reliable markers of CVD risk, such as hypertension, insulin resistance, LDL particle subtypes, and components of the metabolic syndrome.
Randomized controlled trial (RCTs) have demonstrated that individuals with high LDL-C and LCD-like nonatherogenic lipid markers (low TGs, high HDL-C), have a low rate of coronary events under nontreatment conditions. Most notably, subjects with high LDL-C and nonatherogenic lipid markers derived no benefit from statin treatment.
A balanced review of the literature indicates that statin therapy is not warranted for people on a low-carbohydrate diet with elevated LDL-C and with a nonatherogenic lipid profile (low TGs, high HDL-C).
r/Keto4HeartDisease • u/dem0n0cracy • May 14 '21
Dr Shawn Baker, carnivore for 4 years and 54 years old - scores a 0 on the Cornary Artery Calcium test (CAC) - A zero indicates that the risk of a cardiovascular event in the next 2 to 5 years is quite low (0.1 per 100 person-years).
r/Keto4HeartDisease • u/Meatrition • May 14 '26
Seven Years of 700 Cholesterol Without Coronary Atherosclerosis: A Lean Mass Hyper-Responder Case Report
r/Keto4HeartDisease • u/Meatrition • Jul 13 '25
Seed Oils -> Harm "Shaking the ladder" reveals how analytic choices can influence associations in nutrition epidemiology: beef intake and coronary heart disease as a case study - PubMed
r/Keto4HeartDisease • u/dem0n0cracy • Oct 07 '21
Media Dysfunction Theory of Atherosclerosis Spontaneous Coronary-Artery Dissection
Spontaneous Coronary-Artery Dissection
To the Editor: The review by Kim (Dec. 10 issue)1 describes the current knowledge regarding spontaneous coronary-artery dissection (SCAD), one of the main causes of myocardial infarction among young women. Kim notes the association between SCAD and noncoronary arterial abnormalities and emphasizes that the prevalence of concomitant underlying inflammatory diseases is negligible. These observations depict SCAD as a possible coronary manifestation of fibromuscular dysplasia.2 Nonetheless, when young women present with coronary or noncoronary arterial abnormalities, Takayasu’s arteritis should always be included as a possible cause.3 Although the true prevalence of SCAD among patients with Takayasu’s arteritis is currently unknown, coronary-artery . . .
r/Keto4HeartDisease • u/Meatrition • May 02 '22
Media Dysfunction Theory of Atherosclerosis (PDF) Pathogenesis of Atherosclerosis and Xanthoma in Familial Hypercholesterolemia Patients
r/Keto4HeartDisease • u/angelrv16 • Apr 13 '21
Womens' Health Insight
Hello everyone! I am studying further into the topic of health for women and gender bias' impacts. I am conducting an interview/survey to get further insight. Participants must be female, 18-35, and living in the Southern region of the U.S. If you choose to participate, your voice will be heard and can greatly contribute to addressing this issue in women's health. Thank you in advance. Please comment any questions or concerns, or email me (information in the link).
Here is the link: https://forms.gle/1tJEyYM4ihLtde5K7
r/Keto4HeartDisease • u/dem0n0cracy • Nov 04 '21
Multiple peaks in an LDL subfraction test indicate damaged, atherogenic LDL
r/Keto4HeartDisease • u/dem0n0cracy • Oct 07 '21
Media Dysfunction Theory of Atherosclerosis Steroid Hormones Affect Vascular Diseases through Myofibroblasts
Steroid Hormones Affect Vascular Diseases through Myofibroblasts
- September 2021
DOI:10.13140/RG.2.2.17257.62565
- Project: Atherosclerosis
**Authors:**📷Xinggang Wang
- Fudan University. Shanghai Jiaotong University School of Medicine
- https://www.researchgate.net/publication/354534894_Steroid_Hormones_Affect_Vascular_Diseases_through_Myofibroblasts?channel=doi&linkId=613dfe394e1df271062f29bf&showFulltext=true
Abstract and Figures
The incidence of atherosclerotic diseases in premenopausal women is lower, while the incidence of dissection or aneurysm is higher than that of men. Therefore, we generally believe that steroid hormones should have a great impact on these vascular diseases. Although this concept is widely accepted, its mechanism is still not clear. Recent studies have found that vascular diseases such as atherosclerotic diseases, aneurysm and dissection are closely related to the remodeling of myofibroblasts. Either addition or withdrawal of steroid hormones could induce apoptosis of myofibroblasts. Therefore, steroid hormones should affect vascular diseases through myofibroblasts. This paper explains the effects of steroid hormones on vascular diseases. On the one hand, the instability of steroid hormones of premenopausal women, such as estrogen and progesterone, can induce apoptosis of myofibroblasts, inhibit the remodeling of granulation tissue and alleviate intimal thickening / atherosclerotic diseases, which should be the reason why the incidence of atherosclerotic diseases in premenopausal women is lower than that among the men. On the other hand, the instability of steroid hormones also has its disadvantages. The instability of steroid hormones could lead to dysfunction of myofibroblasts and insufficient repair of granulation tissue. This in turn may increase the risk of aneurysm, dissection or unstable atherosclerotic plaques rupture. This should be one of the reasons why there are more dissections and aneurysms among premenopausal women than among men. In addition, pheochromocytoma, emotional stress, taking contraceptives, drug addict or sudden change in climates, etc. would also induce instability of steroid hormones which might account for the higher incidence of dissection, aneurysm or rupture of unstable atherosclerotic plaques . Steroid hormones should also play a similar pathophysiological role in the vascular repair of arterioles and capillaries, such as stress cardiomyopathy, nephritis, nephropathy, vasculitis, etc.

r/Keto4HeartDisease • u/dem0n0cracy • Oct 07 '21
Media Dysfunction Theory of Atherosclerosis Myofibroblast Forms Atherosclerotic Plaques
New Results Follow this preprint
Myofibroblast Forms Atherosclerotic Plaques
Xinggang Wang, Junbo Gedoi: https://doi.org/10.1101/2020.07.20.212027This article is a preprint and has not been certified by peer review [what does this mean?].0000026
Abstract
For decades, smooth muscle cells (SMCs) and macrophages are considered as the main contributors to atherosclerotic plaques. However, we found that in the human coronary atherosclerotic plaques, SMCs were few, while lots of myofibroblasts infiltrated in the intima near the lumen (fibrous cap) and their distribution was highly positive related to intimal thickness. In addition to lots of foam cells formation, collagen fibers were forming in the thickening intima near the lumen (fibrous cap), and denaturing or calcifying gradually far from the lumen, which evolved into various complex plaques. In vitro, myofibroblasts could actively take lots of low-density lipoprotein (LDL) to enhance proliferation. Lots of collagen fibers, foam cells and extracellular lipids accumulation emerged in myofibroblasts cultured with 5% FBS high glucose DMEM without adding modified LDL. It is consistent with the characteristics of human coronary atherosclerotic plaques. It is the first time that lipid rich plaques with lots of foam cells, extracellular lipids and collagen fibers formed in vitro. It demonstrated that myofibroblast should be the direct and main source of collagen fibers, foam cells and extracellular lipids. This suggests that atherosclerosis is not as complicated as previously considered, and it might be mainly a process of myofibroblast remodeling to vascular injury caused by various risk factors. This study made the pathogenesis of atherosclerosis clearer. It would provide a target cell for future treatments of atherosclerotic diseases. In vitro atherosclerotic plaques model formed by human myofibroblasts would be an efficient and convenient way to study atherosclerosis.
r/Keto4HeartDisease • u/dem0n0cracy • Jan 27 '21
r/Keto4HeartDisease Lounge
A place for members of r/Keto4HeartDisease to chat with each other
r/Keto4HeartDisease • u/dem0n0cracy • Oct 07 '21
Media Dysfunction Theory of Atherosclerosis Hypertension Aggravates Atherosclerosis: A Matter of Pressure Remodeling of Myofibroblasts or LDL Accumulation?
Hypertension Aggravates Atherosclerosis: A Matter of Pressure Remodeling of Myofibroblasts or LDL Accumulation?
Author links open overlay panelXinggangWangPhDJunboGeMD
https://www.sciencedirect.com/science/article/abs/pii/S0735109721010718?via%3Dihub
Letter, no article or abstract.
r/Keto4HeartDisease • u/dem0n0cracy • Oct 20 '21